U.S. markets open in 47 minutes

Orexo AB (publ) (ORXOY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
4.9100+0.0500 (+1.03%)
At close: 9:30AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.8600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.9100 - 4.9100
52 Week Range4.7620 - 9.0000
Avg. Volume104
Market Cap168.388M
Beta (5Y Monthly)0.63
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • PR Newswire

    Orexo continues to strengthen ZUBSOLV´s patent portfolio with two new patents

    Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office (USPTO) has issued another two patents relating to ZUBSOLV®, Orexo's sublingual buprenorphine and naloxone tablet (CII) for the treatment of opioid use disorder.

  • PR Newswire

    Orexo Q1 2021 Interim Report

    Q1 2021 summary

  • Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

    Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”. REGISTER OR LOGIN AT: https://bit.ly/3tThRej March 25th Presenting Companies: Presenting CompanyTicker(s)MagicMed Industries Inc.Ticker PendingSernova Corp.OTCQB: SEOVF | TSX-V: SVAVolitionRx LimitedNYSE AMERICAN: VNRXSkylight Health Group Inc.OTCQX: SHGFF | TSX-V:SHGElse Nutrition Holdings Inc.OTCQX: BABYF | TSX-V: BABYCardiol Therapeutics Inc.OTCQX: CRTPF | TSX: CRDLEarthRenew Inc.OTCQB: VVIVF | CSE: ERTHAvicanna Inc.OTCQX: AVCNF | TSX: AVCNOrexo ABOTCQX: ORXOY | STO: ORXCloudMD Software & Services Inc.Pink: DOCRF | TSX-V: DOC To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com. About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors. A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. CONTACT: CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com